UPDATE 1-Merck buys rights to NewLink's experimental Ebola vaccine
November 24, 2014 at 10:38 AM EST
Nov 24 (Reuters) - Merck & Co Inc on Monday said it would buy worldwide commercial rights to NewLink Genetics Corp's experimental vaccine meant to prevent infection with the Ebola virus.
